Big Pharma Could Buy This At Three Times the Current Price
I am not a fan of MNKD b/c I think inhaled insulin has a ton of hurdles even if it works. But diabetes is probably the fastest growing mkt out there and more attractive to big pharma then cancer at this point. I expect huge things out of BIOD over the long term (stock over $50/share). And a big run up short term too.